Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Prospective MRI and Neurocognitive Assessment of “Chemobrain” in Acute Myeloid Leukaemia: The Mineral Study

Ashleigh Scott, Ada Lo, Kate Thompson, Ying Xia, Harriet Bodimeade, Amir Fazlollahi, Cameron Curley, Steven W. Lane, Kirk Lachlan Morris, Caroline Jane McNamara, Elango S. Pillai, Nicholas Weber, Olivier Salvado, Katie L McMahon, Glen A Kennedy

Blood (2023) 142 (Supplement 1): 5850.

https://doi.org/10.1182/blood-2023-190301

Published: 2023

Journal Articles

Real-World Outcomes with CD19 CAR T-Cell Therapy for B-Cell Malignancies in Regional/Rural Australia: Results from the Queensland CAR T-Cell Program

Nilu Perera, Ashleigh P Scott, Stewart Hunt, Cameron Curley, Siok-Keen Tey, Jason Butler, Andrea S Henden, Elango S. Pillai, Cheryl Hutchins, Kari Louise Mudie, Glen A Kennedy

Blood (2022) 140 (Supplement 1): 7500–7501.

https://doi.org/10.1182/blood-2022-168399

Published: 2022

Journal Articles

A phase 3 double-blind study of the addition of tocilizumab vs placebo to cyclosporin/methotrexate GVHD prophylaxis

Blood (2021) 137 (14): 1970–1979.

https://doi.org/10.1182/blood.2020009050

Published: 2021

Includes: Supplemental data

Journal Articles

An Australasian Bone Marrow Transplant Registry (ABMTR) Study of the Trends and Outcomes of Allogeneic Haematopoietic Stem Cell Transplantation (HSCT) in Hodgkin Lymphoma between 2009-2019: Relapse Remains the Most Common Cause of Death Post Transplantation

Kirsty M Sharplin, MBBS, David Ritchie, MB ChB, PhD FRACP, FRCPA, David Gottlieb, MBBS, MD FRACP, FRCPA, Ian Bilmon, BMBS, FRACP, FRCPA, Shyam Panicker, MBBS,MDMRCP,FRACP,FRCPA, Glen A Kennedy, MBBS FRACP FRCPA, Cameron Curley, MBBS, FRACP, FRCPA, Duncan Purtill, MBBS,FRCPA,FRACP, Julian Cooney, FRACP,FRCPA,MBBS,, Richard Doocey, MB ChB, FRACP, FRCPA, Leanne Berkahn, MD, Sam Milliken, MBBS, FRACP, FRCPA, Pietro R Di Ciaccio, BA/LLB MBBS FRACP FRCPA, Peter G Bardy, MBBS, FRACP, FRCPA, FRCPath, Andrew Spencer, David J. Curtis, MBBS,PhD, Sushrut S. Patil, Stephen R Larsen, MBBS PhDFRACP FRCPA, Travis Perera, MB ChB, FRACP, FRCPA, Andrew Butler, MB ChB(Edin), MRCP, MRCPath, Matthew Greenwood, MBBS, FRACP, FRCPA, Anne-Marie Watson, FRACP, FRCPA, MBBS, Hock Choong Lai, MBBS, FRACP, FRCPA, Eric Wong, MDPhD FRACP, FRCPA, Steven Tran, BEng MBiomedE, Nada Hamad, MBBS,BSc,MSc,FRACP FRCPA

Blood (2020) 136 (Supplement 1): 36–37.

https://doi.org/10.1182/blood-2020-138684

Published: 2020

Journal Articles

Improvement in Non-Relapse Mortality Following Allogeneic Transplantation for Chronic Lymphocytic Leukaemia in Australia and New Zealand: An Australasian Bone Marrow Transplant Recipient Registry Study

Blood (2020) 136 (Supplement 1): 25–26.

https://doi.org/10.1182/blood-2020-136574

Published: 2020

Journal Articles

Allogeneic Stem Cell Transplantation for Mantle Cell Lymphoma Can Achieve Durable Remission and Myeloablative Conditioning Is Associated with Inferior Survival: An Australasian Bone Marrow Transplant Recipient Registry Study

Pietro R Di Ciaccio, BA/LLB MBBS FRACP FRCPA, David Ritchie, MB ChB, PhD FRACP, FRCPA, Glen A Kennedy, MBBS FRACP FRCPA, Sam Milliken, MBBS, FRACP, FRCPA, Duncan Purtill, MBBS,FRCPA,FRACP, David Gottlieb, MBBS, MD FRACP, FRCPA, Travis Perera, MB ChB, FRACP, FRCPA, David T Yeung, BSc,PhDFRACP,FRCPA,MBBS, Stephen R Larsen, MBBS PhDFRACP FRCPA, Richard Doocey, MB ChB, FRACP, FRCPA, Matthew Greenwood, MBBS, FRACP, FRCPA, Simon Durrant, MBBS FRCP FRCPath, Anne-Marie Watson, FRACP, FRCPA, MBBS, Andrew Butler, MB ChB(Edin), MRCP, MRCPath, Amit Khot, MBBS, MD MRCP, FRCPath, FRACP, Cameron Curley, MBBS, FRACP, FRCPA, Nada Hamad, MBBS,BSc,MSc,FRACP FRCPA

Blood (2020) 136 (Supplement 1): 7–8.

https://doi.org/10.1182/blood-2020-139057

Published: 2020

Journal Articles

Allogeneic Stem Cell Transplantation for Diffuse Large B Cell Lymphoma Can Achieve Durable Remissions: An Australasian Bone Marrow Transplant Recipient Registry Study

Pietro R Di Ciaccio, BA/LLB MBBS FRACP FRCPA, Matthew Greenwood, MBBS, FRACP, FRCPA, Glen A Kennedy, MBBS FRACP FRCPA, Sam Milliken, MBBS, FRACP, FRCPA, David Gottlieb, MBBS, MD FRACP, FRCPA, David Ritchie, MB ChB, PhD FRACP, FRCPA, Duncan Purtill, MBBS,FRCPA,FRACP, Stephen R Larsen, MBBS PhDFRACP FRCPA, Andrew Spencer, Travis Perera, MB ChB, FRACP, FRCPA, David T Yeung, BSc,PhDFRACP,FRCPA,MBBS, Simon Durrant, MBBS FRCP FRCPath, Andrew Butler, MB ChB(Edin), MRCP, MRCPath, Anne-Marie Watson, FRACP, FRCPA, MBBS, Hock Choong Lai, MBBS, FRACP, FRCPA, Richard Doocey, MB ChB, FRACP, FRCPA, Hugh J. Goodman, FRACP, Ian H. Kerridge, FRACP FRCPA MPhil BA, Christopher Arthur, Cameron Curley, MBBS, FRACP, FRCPA, Caroline Stewart, Kenneth P. Micklethwaite, MBBS, PhD FRACP, FRCPA, Jennifer Collins, Julian Cooney, FRACP,FRCPA,MBBS,, Nada Hamad, MBBS,BSc,MSc,FRACP FRCPA

Blood (2020) 136 (Supplement 1): 18–19.

https://doi.org/10.1182/blood-2020-139076

Published: 2020

Journal Articles

Results of a Phase III Double-Blind Study of the Addition of Tocilizumab Vs. Placebo to Cyclosporin/Methotrexate Gvhd Prophylaxis after HLA-Matched Allogeneic Stem Cell Transplantation

Glen A Kennedy, MBBS FRACP FRCPA, Siok-Keen Tey, MBBS,PhDFRACP,FRCPA, Cameron Curley, MBBS, FRACP, FRCPA, Jason P Butler, MBBS, MMedSc, FRACP, FRCPA, Ashish Misra, MBBS, FRACP, Elango Subramoniapillai, MBBS, FRACP, James Morton, MBBS, FRACP, FRCPA, Simon Durrant, FRCP,FRCPath,MBBS, Andrea S Hendon, MBBS, PhD FRACP, FRCPA, John Moore, MDFRACP,FRCPA, David Ritchie, MD PhD, David Gottlieb, MBBS, MD FRACP, FRCPA, Julian Cooney, FRACP,FRCPA,MBBS,, Luke Buizen, BSc (Hons), MSc, Sanjoy K Paul, PhD, Geoff R. Hill, MD

Blood (2019) 134 (Supplement_1): 368.

https://doi.org/10.1182/blood-2019-126285

Published: 2019

Journal Articles

Comparison of Dinakara and Cotes Method on Correction of Diffusion Limit of Carbon Monoxide and the Impact on Outcomes of Hematopoietic Cell Transplantation-Specific Comorbidity Index (HCT-CI)

Tzu-Yang Wang, MBBS, Jason P Butler, MBBS, MMedSc, FRACP, FRCPA, Cameron Curley, MBBS, FRACP, FRCPA, Glen Kennedy, MBBS, FRACP, FRCPA

Blood (2017) 130 (Supplement 1): 5542.

https://doi.org/10.1182/blood.V130.Suppl_1.5542.5542

Published: 2017

Journal Articles

Early Acute Kidney Injury Post Allogeneic Hematopoetic Progenitor Cell Transplant Is Associated with Increased Risk of Gvhd, Higher Mortality and Reduced Survival

Andrew Birchley, BSc, MBBS, Jason P Butler, MBBS, MMedSc, FRACP, FRCPA, Ashleigh Scott, MBBS, Cameron Curley, MBBS, FRACP, FRCPA, Glen Kennedy, MBBS, FRACP, FRCPA

Blood (2016) 128 (22): 2227.

https://doi.org/10.1182/blood.V128.22.2227.2227

Published: 2016

Journal Articles

A Randomized Trial of Olanzapine and Palonosetron versus Infused Ondansetron for the Treatment of Chemotherapy Induced Nausea and Vomiting in Patients Undergoing Hematopoietic Stem Cell Transplantation

Midori Nakagaki, BPharm, MSc, BCOP, Michael Barras, BPharm, GradDipClinPharm, PhD, Cameron Curley, MBBS, FRACP, FRCPA, Jason P Butler, MBBS, MMedSc, FRACP, FRCPA, Glen A Kennedy, MBBS, FRACP, FRCPA

Blood (2015) 126 (23): 1910.

https://doi.org/10.1182/blood.V126.23.1910.1910

Published: 2015

Journal Articles

Allogeneic Stem Cell Transplantation (allo-SCT) for Chronic Myelomonocytic Leukemia – a Multicentre Australian Experience: Prognostic Factors for Survival and Relapse

Ashish R. Bajel, MBBS, FRACP, FRCPA, Cameron Curley, MBBS, FRACP, FRCPA, Andrew Boon Ming Lim, MBBS, FRACP, FRCPA, Sasanka Handunnetti, MBBS, Bartlomiej Getta, MBBS,, Philip A Thompson, MBBS, FRACP, FRCPA, Matthew P.F. Wright, MBBS,FRCPA,FRACP, Matthew Greenwood, MD FRACP, FRCPA, Mark S Hertzberg, MBBS PhDFRACP FRCPA, David J. Curtis, MD, PhD, Jeffrey Szer, MBBS, FRACP, Glen A Kennedy, MBBS, FRACP, FRCPA, David Ritchie, MBBS, PhD FRACP, FRCPA

Blood (2014) 124 (21): 1927.

https://doi.org/10.1182/blood.V124.21.1927.1927

Published: 2014

Journal Articles

Platelet Transfusion Refractoriness Pre-Allograft Is Associated with Higher Rates of Platelet Non-Engraftment and Graft Failure in Adult Allogeneic Haematopoietic Stem Cell Transplantation for Haematological Malignancies

Ashleigh Scott, MBBS, Stephanie Buckby, MBBS, Shoma Baidya, MBBS,MDFRCPA, Cameron Curley, MBBS FRACP FRCPA, Kirk Lachlan Morris, FRACP,FRCPA,MBBS, MB, BS, Gail Pahn, Glen A Kennedy

Blood (2014) 124 (21): 1143.

https://doi.org/10.1182/blood.V124.21.1143.1143

Published: 2014

Journal Articles

Outpatient Administration Of Hyper-CVAD Chemotherapy For Acute Lymphoblastic Leukaemia / Lymphoma Is Safe and Associated With Similar Toxicity Compared To Inpatient Delivery

Emad Uddin Abro, Kirk Morris, Georgina Hodges, Jason P Butler, Cameron Curley, Elango Subramonia Pillai, Glen A Kennedy

Blood (2013) 122 (21): 5017.

https://doi.org/10.1182/blood.V122.21.5017.5017

Published: 2013

Journal Articles

The Addition Of Interleukin-6 Inhibition To Standard Gvhd Prophylaxis Prevents Acute Gvhd: Interim Results Of a Phase I/II Clinical Study

Glen A Kennedy, Antiopi Varelias, Slavica Vuckovic, Ping Zhang, Kelli PA MacDonald, Justine Leach, Elise Sturgeon, Judy Avery, Stuart D Olver, Mary Lor, Cheryl J Hutchins, James A Morton, Simon TS Durrant, Ashish Misra, Elango Subramoniapillai, Jason P Butler, Cameron Curley, Siok K Tey, Geoffrey R Hill

Blood (2013) 122 (21): 908.

https://doi.org/10.1182/blood.V122.21.908.908

Published: 2013

Journal Articles

Results of a Prospective Phase II Randomized Study of Deferasirox (Exjade®) to Prevent Iatrogenic Iron Overload in Patients Undertaking Induction/Consolidation Chemotherapy for Acute Myeloid Leukaemia (HREC/10/QRBW/135)

Glen A Kennedy, MBBS FRACP FRCPA, Kirk Morris, MBBS FRACP FRCPA, Elango Pillai, MBBS FRACP FRCPA, Cameron Curley, MBBS FRACP FRCPA, Jason P. Butler, MBBS, FRACP, FRCPA, MMSc, Simon Durrant

Blood (2012) 120 (21): 3577.

https://doi.org/10.1182/blood.V120.21.3577.3577

Published: 2012

NARROW

Prospective MRI and Neurocognitive Assessment of “Chemobrain” in Acute Myeloid Leukaemia: The Mineral Study

Real-World Outcomes with CD19 CAR T-Cell Therapy for B-Cell Malignancies in Regional/Rural Australia: Results from the Queensland CAR T-Cell Program

A phase 3 double-blind study of the addition of tocilizumab vs placebo to cyclosporin/methotrexate GVHD prophylaxis

An Australasian Bone Marrow Transplant Registry (ABMTR) Study of the Trends and Outcomes of Allogeneic Haematopoietic Stem Cell Transplantation (HSCT) in Hodgkin Lymphoma between 2009-2019: Relapse Remains the Most Common Cause of Death Post Transplantation

Improvement in Non-Relapse Mortality Following Allogeneic Transplantation for Chronic Lymphocytic Leukaemia in Australia and New Zealand: An Australasian Bone Marrow Transplant Recipient Registry Study

Allogeneic Stem Cell Transplantation for Mantle Cell Lymphoma Can Achieve Durable Remission and Myeloablative Conditioning Is Associated with Inferior Survival: An Australasian Bone Marrow Transplant Recipient Registry Study

Allogeneic Stem Cell Transplantation for Diffuse Large B Cell Lymphoma Can Achieve Durable Remissions: An Australasian Bone Marrow Transplant Recipient Registry Study

Results of a Phase III Double-Blind Study of the Addition of Tocilizumab Vs. Placebo to Cyclosporin/Methotrexate Gvhd Prophylaxis after HLA-Matched Allogeneic Stem Cell Transplantation

Comparison of Dinakara and Cotes Method on Correction of Diffusion Limit of Carbon Monoxide and the Impact on Outcomes of Hematopoietic Cell Transplantation-Specific Comorbidity Index (HCT-CI)

Early Acute Kidney Injury Post Allogeneic Hematopoetic Progenitor Cell Transplant Is Associated with Increased Risk of Gvhd, Higher Mortality and Reduced Survival

A Randomized Trial of Olanzapine and Palonosetron versus Infused Ondansetron for the Treatment of Chemotherapy Induced Nausea and Vomiting in Patients Undergoing Hematopoietic Stem Cell Transplantation

Allogeneic Stem Cell Transplantation (allo-SCT) for Chronic Myelomonocytic Leukemia – a Multicentre Australian Experience: Prognostic Factors for Survival and Relapse

Platelet Transfusion Refractoriness Pre-Allograft Is Associated with Higher Rates of Platelet Non-Engraftment and Graft Failure in Adult Allogeneic Haematopoietic Stem Cell Transplantation for Haematological Malignancies

Outpatient Administration Of Hyper-CVAD Chemotherapy For Acute Lymphoblastic Leukaemia / Lymphoma Is Safe and Associated With Similar Toxicity Compared To Inpatient Delivery

The Addition Of Interleukin-6 Inhibition To Standard Gvhd Prophylaxis Prevents Acute Gvhd: Interim Results Of a Phase I/II Clinical Study

Results of a Prospective Phase II Randomized Study of Deferasirox (Exjade®) to Prevent Iatrogenic Iron Overload in Patients Undertaking Induction/Consolidation Chemotherapy for Acute Myeloid Leukaemia (HREC/10/QRBW/135)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only